DE60217900D1 - Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung - Google Patents

Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung

Info

Publication number
DE60217900D1
DE60217900D1 DE60217900T DE60217900T DE60217900D1 DE 60217900 D1 DE60217900 D1 DE 60217900D1 DE 60217900 T DE60217900 T DE 60217900T DE 60217900 T DE60217900 T DE 60217900T DE 60217900 D1 DE60217900 D1 DE 60217900D1
Authority
DE
Germany
Prior art keywords
avermectin compound
dermatoses
treatment
kit
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60217900T
Other languages
English (en)
Other versions
DE60217900T2 (de
Inventor
L Dean Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60217900D1 publication Critical patent/DE60217900D1/de
Publication of DE60217900T2 publication Critical patent/DE60217900T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60217900T 2001-10-12 2002-10-03 Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung Expired - Lifetime DE60217900T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/976,915 US6399651B1 (en) 2000-06-29 2001-10-12 Method of treating dermatoses using avermectin compound
US976915 2001-10-12
PCT/US2002/032001 WO2003032976A1 (en) 2001-10-12 2002-10-03 Method of treating dermatoses using avermectin compound

Publications (2)

Publication Number Publication Date
DE60217900D1 true DE60217900D1 (de) 2007-03-15
DE60217900T2 DE60217900T2 (de) 2007-11-08

Family

ID=25524622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217900T Expired - Lifetime DE60217900T2 (de) 2001-10-12 2002-10-03 Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung

Country Status (9)

Country Link
US (2) US6399651B1 (de)
EP (1) EP1450785B1 (de)
AT (1) ATE352298T1 (de)
CY (1) CY1106528T1 (de)
DE (1) DE60217900T2 (de)
DK (1) DK1450785T3 (de)
ES (1) ES2278046T3 (de)
PT (2) PT1450785E (de)
WO (1) WO2003032976A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
RU2350333C3 (ru) * 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7714015B2 (en) * 2003-08-07 2010-05-11 Lil Brat Pharmaceuticals Of Marlette, Mi Method and composition for treating sunburned skin
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) * 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906468B1 (fr) * 2006-09-28 2012-09-21 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
US8791153B2 (en) 2006-10-12 2014-07-29 Sanofi-Topaz, Inc. Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
US20080226701A1 (en) * 2007-03-15 2008-09-18 John Deignan Medicated patches
US8541022B2 (en) * 2008-06-02 2013-09-24 Galderma S.A. Method of treating burns using avermectin compound
FR2937972B1 (fr) 2008-11-04 2013-03-29 Galderma Res & Dev Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
CA2811924C (en) 2010-10-20 2015-06-16 Galderma S.A. Method of treating hemorrhoids using macrocyclic lactone compound
CA2811926A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
US8722636B2 (en) * 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
CN102599178B (zh) * 2012-02-13 2013-11-27 中国水稻研究所 异丙威和依维菌素复配农药
AU2012379005B2 (en) 2012-05-02 2017-12-21 Newmarket Pharmaceuticals Llc Pharmaceutical compositions for direct systemic introduction
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233117B2 (en) 2013-07-08 2016-01-12 Galderma S. A. Treatment of inflammatory lesions of rosacea with ivermectin
EP3074021B1 (de) * 2013-11-29 2021-05-12 Galderma SA Verbindung der avermectin-familie oder der milbemycin-familie zur behandlung und/oder prävention von atopischer dermatitis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6057372A (en) * 1996-06-11 2000-05-02 Soda Aromatic Co., Ltd. Antibacterial agents and cosmetics and clothing containing the same
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6262031B1 (en) * 1999-03-12 2001-07-17 Merck & Co., Inc. Method for treating pediculosis capitisinfestation
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound

Also Published As

Publication number Publication date
ATE352298T1 (de) 2007-02-15
US20020156029A1 (en) 2002-10-24
PT1439832E (pt) 2007-06-05
EP1450785A1 (de) 2004-09-01
US6399651B1 (en) 2002-06-04
ES2278046T3 (es) 2007-08-01
DE60217900T2 (de) 2007-11-08
EP1450785B1 (de) 2007-01-24
EP1450785A4 (de) 2005-01-05
US20020035076A1 (en) 2002-03-21
WO2003032976A1 (en) 2003-04-24
DK1450785T3 (da) 2007-05-14
PT1450785E (pt) 2007-04-30
CY1106528T1 (el) 2012-01-25

Similar Documents

Publication Publication Date Title
DE60217900D1 (de) Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung
ES2159309T3 (es) Semillas tratadas.
BRPI0418745A (pt) anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
BRPI0506977A (pt) composto de tetrahidrocarbolina como agentes anticáncer
PT1543011E (pt) Composto de tienopirrolilo e furanopirrolilo e sua utilizacao como ligandos do receptor h4 da histamina
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
NO20053649L (no) Kombinasjonsterapi
BR0312078A (pt) controle de informações de localização geográfica de dispositivos que operam em sistemas de comunicação sem fio
WO2005000213A3 (en) Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
BRPI0511187A (pt) método para tratar cáncer em um indivìduo
WO2005105094A3 (en) Cancer treatment method
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
DE602004022285D1 (de) Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
BR0215362A (pt) método para melhorar a aparência estética da pele
WO2015017328A3 (en) Organophosphates for treating afflictions of the skin
WO2003103473A3 (en) APPARATUS AND METHOD FOR SURGICAL INTERVENTION
DK1276482T3 (da) Kombinationskemoterapi
MY135460A (en) Method of stimulating hair growth using benzopyrans
WO2003092669A3 (en) Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
ATE516038T1 (de) Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition